No Data
Cytek Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Today Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Cytek Biosciences Price Target Cut to $8.50/Share From $10.00 by Piper Sandler
Cytek Biosciences Price Target Cut to $8.50/Share From $10.00 by Piper Sandler
Cytek Biosciences Is Maintained at Overweight by Piper Sandler
Cytek Biosciences Is Maintained at Overweight by Piper Sandler
Piper Sandler: Maintaining the Cytek Biosciences (CTKB.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $10.00 to $8.50.
Piper Sandler: Maintaining the Cytek Biosciences (CTKB.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $10.00 to $8.50.
Piper Sandler Maintains Overweight on Cytek Biosciences, Lowers Price Target to $8.5
Piper Sandler analyst David Westenberg maintains Cytek Biosciences (NASDAQ:CTKB) with a Overweight and lowers the price target from $10 to $8.5.